Thursday, 18 Jan 2018

You are here

NLRP3 Activation in Still's Disease

Adult-onset Still disease (AOSD) is usually regarded as an autoinflammatory disease, largely because of its symptomatology and responsiveness to IL-1 inhibition.  Thus while it is assumed that aberrant NLRP3 inflammasome activity underlies active AOSD, the connection between NLRP3 AOSD has yet to be solidfied.

Hseih et al have studied mRNA expression of NLRP3 inflammasome signaling using quantitative-PCR (qPCR) on peripheral blood mononuclear cells (PBMC) from 34 patients with AOSD and 14 healthy subjects. These results were either augmented with a NLRP3 activator [imiquimod (IMQ)] or inhibitor.

AOSD patients demonstrated significantly higher mRNA levels of NLRP3 signaling compared with controls. Moreover, NLRP3 expression was positively correlated with AOSD disease activity

IMQ (a TLR7 ligand and activator) stimulated higher expression of NLRP3, caspase-1 and IL-18.  These were decreased after treatment with NLRP3 inhibitor in patients with AOSD.

Increased expression of NLRP3 inflammasome and its correlation with disease activity in AOSD suggest its involvement in disease pathogenesis of AOSD.  Currently the inducers of NLRP3 activity in AOSD are unknown and would make for an ideal treatment target in the future.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

IL-1 and IL-6 Inhibition Preferred in Systemic JIA

Since 2000, the German Biologics register (BiKeR) has prospectively enrolled children with juvenile idiopathic arthritis to assess outcomes with biologic therapies.  A new report evaluates the efficacy and safety of etanercept (ETA), tocilizumab (TOC) and the interleukin-1 inhibitors (anakinra and canakinumab) (IL-1i) in those with systemic onset juvenile idiopathic arthritis JIA (sJIA).

Increasing Adverse Events Seen with Higher Disease Activity in Early RA

Researchers in the NEO-RACo Study Group studied adverse events (AEs) in relation to disease activity in patients with early rheumatoid arthritis (RA).

Small Joint Surgeries Drop Among RA Patients

The rate of small - but not large - joint surgery has dropped among patients with rheumatoid arthritis since 1995, a retrospective review of orthopedic surgeries found. By 2015, less than 1% of patients per year underwent small joint surgery, reported Ashima Makol, MD, of the Mayo Clinic in Rochester, Minnesota, and colleagues in Arthritis Care & Research. 

Despite Increasing Metric Use, They Are Not Widespread in Rheumatoid Care

The Journal of Rheumatology has published a nationwide survey of US rheumatologists and shown that despite trends for increasing metric assessments, nearly half of rheumatoid arthritis (RA) patients are not routinely assessed with a disease activity metric and the evidence they use these in a treat-to-target (T2T) practice is lacking.

Bone Marrow Edema May be Found in Normals, Athletes and Military Recruits

Rheumatology has published a study demonstrating that bone marrow edema as measured by magnetic resonance imaging (MRI) may be found in healthy people, but that such changes do not change with intense physical activity.